MCID: VLV047
MIFTS: 50

Volvulus of Midgut

Categories: Fetal diseases, Gastrointestinal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Volvulus of Midgut

MalaCards integrated aliases for Volvulus of Midgut:

Name: Volvulus of Midgut 56 12
Volvulus 12 29 54 15 32
Intestinal Volvulus 12 43 15 17
Familial Intestinal Malrotation 12 58
Twist of Intestine, Bowel, or Colon 12
Intestinal Malrotation, Familial 56

Characteristics:

OMIM:

56
Inheritance:
autosomal dominant


HPO:

31
volvulus of midgut:
Inheritance autosomal dominant inheritance


Classifications:

Orphanet: 58  
Developmental anomalies during embryogenesis


External Ids:

Disease Ontology 12 DOID:8445
OMIM 56 193250
ICD9CM 34 560.2
MeSH 43 D045822
NCIt 49 C98963
SNOMED-CT 67 90738007 9707006
ICD10 32 K56.2
Orphanet 58 ORPHA508410
MedGen 41 C0221210
UMLS 71 C0042961

Summaries for Volvulus of Midgut

Disease Ontology : 12 An intestinal obstruction characterized by abnormal rotation of the intestines.

MalaCards based summary : Volvulus of Midgut, also known as volvulus, is related to filariasis and constipation. An important gene associated with Volvulus of Midgut is LAX1 (Lymphocyte Transmembrane Adaptor 1), and among its related pathways/superpathways is FOXA2 and FOXA3 transcription factor networks. The drugs Ivermectin and Antiparasitic Agents have been mentioned in the context of this disorder. Affiliated tissues include colon, small intestine and liver, and related phenotypes are hypertelorism and frontal bossing

Wikipedia : 74 A volvulus is when a loop of intestine twists around itself and the mesentery that supports it,... more...

More information from OMIM: 193250

Related Diseases for Volvulus of Midgut

Diseases related to Volvulus of Midgut via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 690)
# Related Disease Score Top Affiliating Genes
1 filariasis 31.2 TLR2 CRP ALB
2 constipation 31.2 GCG ATP4A ATP12A APOLD1
3 hernia, hiatus 31.0 LAX1 FOXF1 CRP ATP4A ATP12A
4 peptic ulcer disease 30.9 ATP4A ATP12A ALB
5 cholecystitis 30.7 GPT F2 ALB
6 pneumatosis cystoides intestinalis 30.7 CRP ATP4A ATP12A
7 cascade stomach 30.6 ATP4A ATP12A
8 intussusception 30.6 CRP APOLD1 ALB
9 meckel's diverticulitis 30.4 KCNE1 CRP
10 peritonitis 30.4 TLR2 F2 CRP ALB
11 peptic esophagitis 30.4 ATP4A ATP12A ALB
12 gastric dilatation 30.3 TNNI3 PLA2G2D CRP ATP4A ATP12A
13 ileus 30.3 GUCY2C F2 CRP
14 extrapulmonary tuberculosis 30.3 TLR2 CRP ALB
15 pulmonary tuberculosis 30.3 TLR2 CRP ALB
16 leptin deficiency or dysfunction 30.2 GPT GCG CRP ALB
17 tuberculous peritonitis 30.2 CRP ALB
18 crohn's disease 30.2 TLR2 GCG CRP ALB
19 dipetalonemiasis 30.2 GPT ALB
20 toxic megacolon 30.1 CRP ATP4A ATP12A ALB
21 cholelithiasis 30.1 GPT CRP ALB
22 intestinal obstruction 30.1 GUCY2C GPT CRP ATP4A ATP12A APOLD1
23 abdominal tuberculosis 30.0 F2 CRP ALB
24 disseminated intravascular coagulation 30.0 GPT F2 CRP
25 schistosomiasis 30.0 GPT F2 ALB
26 bronchopneumonia 29.9 GPT CRP ALB
27 clostridium difficile colitis 29.9 CRP ATP4A ATP12A ALB
28 diverticulitis 29.9 CRP ATP4A ATP12A APOLD1 ALB
29 splenic infarction 29.9 GPT F2 CRP
30 meckel diverticulum 29.9 OMD LAX1 GCG CRP APOLD1
31 compartment syndrome 29.8 GPT F2 CRP ALB
32 acute liver failure 29.8 GPT F2 ALB
33 duodenal obstruction 29.8 PLA2G2D ATP4A ATP12A ALB
34 hyperuricemia 29.8 GPT CRP ALB
35 intestinal perforation 29.8 GPT CRP ATP4A ATP12A ALB
36 emphysematous cholecystitis 29.7 GPT F2 CRP
37 portal hypertension 29.6 GPT F2 ALB
38 cholangitis 29.6 GPT F2 CRP ALB
39 paralytic ileus 29.6 GPT F2 CRP ALB
40 obstructive jaundice 29.6 GPT F2 CRP ALB
41 typhoid fever 29.6 GPT F2 CRP ALB
42 hypersplenism 29.6 GPT F2 ALB
43 aspiration pneumonia 29.5 GPT F2 CRP ATP4A ATP12A ALB
44 thrombocytopenia 29.5 TLR2 GPT F2 CRP ALB
45 pneumonia 29.5 TLR2 GPT F2 CRP ALB
46 exanthem 29.4 GPT F2 CRP ATP4A ATP12A ALB
47 cholestasis 29.4 GPT GCG F2 ALB
48 respiratory failure 29.4 GPT F2 CRP ALB
49 cardiac tamponade 29.4 TNNI3 F2 CRP ALB
50 ascending cholangitis 29.4 GPT F2 CRP ALB

Graphical network of the top 20 diseases related to Volvulus of Midgut:



Diseases related to Volvulus of Midgut

Symptoms & Phenotypes for Volvulus of Midgut

Human phenotypes related to Volvulus of Midgut:

58 31 (show all 13)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 hypertelorism 58 31 hallmark (90%) Very frequent (99-80%) HP:0000316
2 frontal bossing 58 31 hallmark (90%) Very frequent (99-80%) HP:0002007
3 depressed nasal bridge 58 31 hallmark (90%) Very frequent (99-80%) HP:0005280
4 anteverted nares 58 31 hallmark (90%) Very frequent (99-80%) HP:0000463
5 high forehead 58 31 hallmark (90%) Very frequent (99-80%) HP:0000348
6 intestinal malrotation 58 31 hallmark (90%) Very frequent (99-80%) HP:0002566
7 long palpebral fissure 58 31 hallmark (90%) Very frequent (99-80%) HP:0000637
8 volvulus 58 31 hallmark (90%) Very frequent (99-80%) HP:0002580
9 constipation 31 HP:0002019
10 telecanthus 31 HP:0000506
11 abdominal distention 31 HP:0003270
12 abnormality of the genitourinary system 31 HP:0000119
13 neonatal intestinal obstruction 31 HP:0005234

Symptoms via clinical synopsis from OMIM:

56
Head:
frontal bossing
high forehead
boxy head

Eyes:
telecanthus
long palpebral fissures

G I:
constipation
intestinal malrotation
neonatal intestinal obstruction
midgut volvulus
abdominal distention and pain
more
G U:
major obstetrical abnormalities

Clinical features from OMIM:

193250

Drugs & Therapeutics for Volvulus of Midgut

Drugs for Volvulus of Midgut (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 53)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ivermectin Approved, Investigational, Vet_approved Phase 4 70288-86-7 6474909
2 Antiparasitic Agents Phase 4
3 Anti-Infective Agents Phase 4
4 Anticonvulsants Phase 4
5 Vitamins Phase 4
6 Pharmaceutical Solutions Phase 4
7 Liver Extracts Phase 4
8 Soybean oil, phospholipid emulsion Phase 4
9 Parenteral Nutrition Solutions Phase 4
10 Fat Emulsions, Intravenous Phase 4
11 Soy Bean Phase 4
12 Antimitotic Agents Phase 3
13 Milbemycin Phase 3
14 Anthelmintics Phase 3
15
Valproic acid Approved, Investigational Phase 2 99-66-1 3121
16
Phenytoin Approved, Vet_approved Phase 2 57-41-0 1775
17
Azithromycin Approved Phase 2 83905-01-5 55185 447043
18
Rifampicin Approved Phase 2 13292-46-1 5458213 5381226
19
Furosemide Approved, Vet_approved Phase 2 54-31-9 3440
20
Albendazole Approved, Vet_approved Phase 2 54965-21-8 2082
21
Diethylcarbamazine Approved, Investigational, Vet_approved Phase 2 90-89-1 3052
22
Doxycycline Approved, Investigational, Vet_approved Phase 2 564-25-0 54671203
23
Pyridoxine Approved, Investigational, Nutraceutical, Vet_approved Phase 2 65-23-6 1054
24
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
25 Kava Approved, Investigational, Nutraceutical Phase 2 9000-38-8
26 Central Nervous System Depressants Phase 2
27 Trace Elements Phase 2
28 Tranquilizing Agents Phase 2
29 Neurotransmitter Agents Phase 2
30 Micronutrients Phase 2
31 Vitamin B Complex Phase 2
32 Nutrients Phase 2
33 Vitamin B 6 Phase 2
34 Sodium Channel Blockers Phase 2
35 GABA Agents Phase 2
36 Psychotropic Drugs Phase 2
37 Vitamin B9 Phase 2
38 Folate Phase 2
39 Antimanic Agents Phase 2
40 Diuretics, Potassium Sparing Phase 2
41 Antitubercular Agents Phase 2
42 Cytochrome P-450 CYP3A Inducers Phase 2
43 Antibiotics, Antitubercular Phase 2
44 diuretics Phase 2
45 Anti-Bacterial Agents Phase 2
46 Antiprotozoal Agents Phase 2
47 Antimalarials Phase 2
48
Pyridoxal Experimental, Nutraceutical Phase 2 66-72-8 1050
49
Praziquantel Approved, Investigational, Vet_approved Phase 1 55268-74-1 4891
50
Emodepside Investigational, Vet_approved Phase 1 155030-63-0

Interventional clinical trials:

(show all 39)
# Name Status NCT ID Phase Drugs
1 Ivermectin Treatment in Patients With Onchocerciasis-associated Epilepsy: A Randomized Clinical Trial Completed NCT03052998 Phase 4 Ivermectin
2 Personalized Versus Standardized Parenteral Nutrition for Preterm Infants With a Birth Weight Greater Than 1250 Grams: a Multicenter Randomized Phase IV Clinical Trial Not yet recruiting NCT03693287 Phase 4 Standardized-parenteral nutrition (S-PN);Personalized-parenteral nutrition (P-PN)
3 Low Dose Parenteral Fat for the Prevention of Parenteral Nutrition Associated Cholestasis in Neonates With Congenital/Acquired Gastrointestinal Disorders Terminated NCT01373918 Phase 4 Intralipid;Intralipid
4 A Single-Dose, Ivermectin-Controlled, Double-Blind, Efficacy, Safety And Tolerability Study Of Orally Administered Moxidectin In Subjects Infected With Onchocerca Volvulus Completed NCT00790998 Phase 3 Moxidectin;Ivermectin
5 Comparison of Ivermectin Alone With Albendazole (ALB) Plus Ivermectin (IVM) in Their Efficacy Against Onchocerciasis Completed NCT03238131 Phase 3 Ivermectin;Albendazole
6 A Randomized, Double Blind, Parallel Trial in the Democratic Republic of Congo (DRC) Comparing the Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Treatment of Onchocerciasis Not yet recruiting NCT03876262 Phase 3 Moxidectin;Ivermectin
7 Treatment of Nodding Syndrome - A Randomized Blinded Placebo-Controlled Crossover Trial of Oral Pyridoxine and Conventional Anti-Epileptic Therapy, in Northern Uganda — 2012 Unknown status NCT01730313 Phase 2 Pyridoxine;Sodium Valproate;Phenytoin;Placebo
8 A Randomized, Single-Ascending Dose, Ivermectin-Controlled, Double-Blind, Safety, Tolerability, Pharmacokinetic, and Efficacy Study Of Orally Administered Moxidectin In Subjects With Onchocerca Volvulus Infection Completed NCT00300768 Phase 2 2 mg moxidectin;ivermectin 150 mcg/kg;4 mg moxidectin;8 mg moxidectin
9 Trial of Rifampin and Azithromycin for Treatment of Endosymbiotic Bacteria (Wolbachia) in Onchocerca Volvulus in Guatemala Completed NCT00127504 Phase 2 Rifampin;Azithromycin
10 MANAGEMENT OF THE PATIENT WITH ACUTE ABDOMEN SUBMITTED TO URGENT ABDOMINAL SURGERY: a Pilot Randomized Multicentre Study Completed NCT01911702 Phase 2
11 Safety and Efficacy of Combination Therapy With Ivermectin, Diethylcarbamazine, and Albendazole (IDA) for Individuals With Onchocerciasis Recruiting NCT04188301 Phase 2 IVM w/ ALB;Single dose of IDA;Three daily doses of IDA
12 Doxycycline for the Treatment of Nodding Syndrome: A Phase II, Randomised Placebo Controlled Trial Recruiting NCT02850913 Phase 2 Doxycycline
13 A Single-Center, Open-Label, Single-Dose Study To Assess The Pharmacokinetics, Safety, And Tolerability Of Moxidectin In Subjects Aged 4 To 11 Years ( >=12 kg) With Or Without Onchocerca Volvulus Infection Withdrawn NCT01035619 Phase 2 moxidectin
14 A Phase 1, Single-Blind, Randomized, Placebo Controlled, Parallel-Group, Multiple-Dose-Escalation Study to Investigate Safety, Tolerability, and Pharmacokinetics of Emodepside (BAY 44-4400) After Oral Dosing in Healthy Male Subjects Completed NCT03383614 Phase 1 LSF emodepside (BAY 44-4400) oral solution (1mg/mL)
15 A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Potential Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers Completed NCT03012828 Phase 1 Moxidectin
16 Phase1,Randomized,Open-Label,Parallel-Group,Relative Bioavailability Study to Investigate PK,Including Food Effect,Safety and Tolerability of Single Doses of New Immediate Release Tablet Formulations of Emodepside (BAY 44-4400),Compared to Oral Solution,in Healthy Male Subjects Completed NCT03383523 Phase 1 Emodepside (BAY 44-4400)
17 Bariatric Embolization Trial for the Obese Nonsurgical Not yet recruiting NCT03601273 Phase 1
18 Multi Center, Observational, Retrospective Data Collection of Patients Treated With the ColonRing in Routine Clinical Practice. This Study to Continue RETROPRESS Study ID NCT01301417 Unknown status NCT01880918
19 The Effect of Combined General-epidural vs General Anaesthesia on Postoperative Intestinal Function Recovery and Infection in Neonates and Infants Undergoing Gastrointestinal Surgery: a Prospective, Randomised, Controlled Trial Unknown status NCT03056261
20 Probiotics Supplementation and Length of Hospital Stay in Neonates With Gastrointestinal Surgery Unknown status NCT03266315
21 Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver Disease Approved for marketing NCT03072667 Omegaven
22 Best Management of Sigmoid Volvulus: A Prospective Randomized Trial Completed NCT01682395
23 Prenatal Diagnosis of Antenatal Midgut Volvulus: Specific Ultrasound Features Completed NCT03362450
24 Prenatal Ultrasound Screening of Intestinal Malrotation With a Higher Risk of Volvulus: Value of The Relative Position of The Superior Mesenteric Artery and Vein. Future of the Children With an Antenatal Malrotation Suspicion Completed NCT03356314
25 a RETROspective Data Collection of comPRESSion Anastomosis Using the ColonRing ™ Completed NCT01301417
26 Determination of the Prevalence of LF Infection in Districts Not Included in LF Control Activities and of the Basis for Integrated Implementation of LF - Onchocerciasis Elimination Strategies in Potentially Co-endemic Areas Completed NCT03131401
27 Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Ivory Coast Completed NCT02032043 Annual versus Semiannual Albendazole plus Ivermectin MDA
28 Optimization of Mass Drug Administration With Existing Drug Regimens for Lymphatic Filariasis and Onchocerciasis for Liberia Completed NCT01905436 Annual versus Semiannual Albendazole plus Ivermectin Mass Drug Administration
29 Health Related Quality of Life of Patients With Abdominal Wall Defects Completed NCT03960320
30 Role of Omega-3 Fish Oil Fatty Acids on Depression Among HIV-seropositive Pregnant Pregnant Women in Nairobi: A Randomized Double-blind Controlled Trial Completed NCT01614249
31 Clinical Features and Potential Etiology of Epilepsy and Nodding Syndrome in the Mahenge Area, Ulanga District Recruiting NCT03653975
32 Host Response to Infection and Treatment in the Filarial Diseases of Humans Recruiting NCT00001230
33 Safety and Efficacy of Endoscopic Assisted Push Gastrostomy Using Gastropexy Technique Recruiting NCT04096456
34 Microfilarial Clearance From the Eye and Ocular Changes Associated With Ivermectin Treatment in Individuals With Onchocerciasis Active, not recruiting NCT03517462 Ivermectin 3Mg Tab
35 Regional Haemoglobin Oxygen Saturation in the Splanchnic Circulation in Neonates With Gastroschisis; Quantifying and Qualifying the Role for Routine Monitoring Active, not recruiting NCT03533439
36 Diagnostic Performance of Antenatal Ultrasound in the Localization of Intestinal Structures Involved in Malrotation With a Higher-risk of Volvulus Not yet recruiting NCT03968107
37 Yield of Colonoscopy in Children With Bleeding Per Rectum Attending Gastrointestinal Endoscopic Unit In Assuit University Children Hospital Not yet recruiting NCT03596320
38 Early Delivery in Fetal Gastroschisis: a Randomized Controlled Trial of Elective Early Delivery Versus Routine Obstetrical Care Terminated NCT01884324
39 Prospective Study of Non-operative Management of SBO Without Nasogastric Tube Placement Withdrawn NCT02530086

Search NIH Clinical Center for Volvulus of Midgut

Cochrane evidence based reviews: intestinal volvulus

Genetic Tests for Volvulus of Midgut

Genetic tests related to Volvulus of Midgut:

# Genetic test Affiliating Genes
1 Volvulus 29

Anatomical Context for Volvulus of Midgut

MalaCards organs/tissues related to Volvulus of Midgut:

40
Colon, Small Intestine, Liver, Skin, Spleen, Heart, Testes

Publications for Volvulus of Midgut

Articles related to Volvulus of Midgut:

(show top 50) (show all 8231)
# Title Authors PMID Year
1
Familial intestinal malrotation with midgut volvulus and facial anomalies: a disorder involving a gene controlling the normal gut rotation? 61 56
1519649 1992
2
Small bowel volvulus in two siblings. 61 56
3135012 1988
3
Familial midgut anomalies--a spectrum of defects due to the same cause? 61 56
7246615 1981
4
Familial midgut volvulus. 61 56
5051163 1972
5
Immunohistological studies on neoplasms of female and male Onchocerca volvulus: filarial origin and absence of Wolbachia from tumor cells. 54 61
20199697 2010
6
Innate immune responses to endosymbiotic Wolbachia bacteria in Brugia malayi and Onchocerca volvulus are dependent on TLR2, TLR6, MyD88, and Mal, but not TLR4, TRIF, or TRAM. 54 61
17202370 2007
7
Ivermectin selection on beta-tubulin: evidence in Onchocerca volvulus and Haemonchus contortus. 54 61
17007942 2006
8
Genetic polymorphism of the beta-tubulin gene of Onchocerca volvulus in ivermectin naïve patients from Cameroon, and its relationship with fertility of the worms. 54 61
16197589 2006
9
Onchocerca volvulus-exposed persons fail to produce interferon-gamma in response to O. volvulus antigen but mount proliferative responses with interleukin-5 and IL-13 production that decrease with increasing microfilarial density. 54 61
11930325 2002
10
Characterization and expression of enzymatically active recombinant filarial prolyl 4-hydroxylase. 54 61
11522351 2001
11
Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria. 54 61
11377205 2001
12
Characterization of the heat-shock protein 60 chaperonin from Onchocerca volvulus. 54 61
10779593 2000
13
T cell responses in coinfection with Onchocerca volvulus and the human immunodeficiency virus type 1. 54 61
9767610 1998
14
Identification of an epitope of a recombinant Onchocerca volvulus protein that induces corneal pathology. 54 61
9297706 1997
15
Molecular characterization and expression of Onchocerca volvulus glutathione reductase. 54 61
9271084 1997
16
Immunoregulation in onchocerciasis: persons with ocular inflammatory disease produce a Th2-like response to Onchocerca volvulus antigen. 54 61
8699070 1996
17
Epitopes of the Onchocerca volvulus RAL1 antigen, a member of the calreticulin family of proteins, recognized by sera from patients with onchocerciasis. 54 61
7520419 1994
18
A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. 54 61
7836063 1994
19
Serological cross-reactivity between a human Ro/SS-A autoantigen (calreticulin) and the lambda Ral-1 antigen of Onchocerca volvulus. 54 61
1602002 1992
20
Analysis of aqueous humour in ocular onchocerciasis. 54 61
2036808 1991
21
Humoral autoimmune response against S-antigen and IRBP in ocular onchocerciasis. 54 61
2365568 1990
22
A human Ro/SS-A autoantigen is the homologue of calreticulin and is highly homologous with onchocercal RAL-1 antigen and an aplysia "memory molecule". 54 61
2365822 1990
23
Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy. 61
31786246 2020
24
American Society for Gastrointestinal Endoscopy guideline on the role of endoscopy in the management of acute colonic pseudo-obstruction and colonic volvulus. 61
31791596 2020
25
Lower Urinary Tract and Bowel Dysfunction in Neurologic Disease. 61
31996628 2020
26
Management of surgical complications of previous bariatric surgery in pregnant women. A systematic review from the BARIA-MAT Study Group. 61
31837948 2020
27
Sigmoidopexy in sigmoid volvulus. 61
32036950 2020
28
Herniation of the caecum and ascending colon through the foramen of Winslow: a case report and review. 61
31532226 2020
29
[Autologous reconstructive surgery and intestinal rehabilitation in the management of short bowel syndrome]. 61
32037869 2020
30
Massive ascites and severe pulmonary hypoplasia in a premature infant with meconium peritonitis and congenital cytomegalovirus infection. 61
31198083 2020
31
Sigmoid volvulus: Coffee bean sign, whirl sign. 61
32015060 2020
32
The Galabat-Metema cross-border onchocerciasis focus: The first coordinated interruption of onchocerciasis transmission in Africa. 61
32027648 2020
33
Description, molecular characteristics and Wolbachia endosymbionts of Onchocerca borneensis Uni, Mat Udin & Takaoka n. sp. (Nematoda: Filarioidea) from the Bornean bearded pig Sus barbatus Müller (Cetartiodactyla: Suidae) of Sarawak, Malaysia. 61
32028994 2020
34
Comment on "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil". 61
32003240 2020
35
Perioperative Outcomes and Predictors of Mortality After Surgery for Sigmoid Volvulus. 61
31415933 2020
36
Comment on sigmoid volvulus treated with colonoscopic decompression followed by snare-assisted side-hole tube placement. 61
31465621 2020
37
Prognostic value of colonic and peripheral venous lactate measurements in horses with large colon volvulus. 61
31916608 2020
38
Recurrent midgut volvulus in an adult patient - The case for pexy? A case report and review of the literature. 61
31821981 2020
39
Authors' reply to comment on "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil". 61
31967485 2020
40
A Case of Torsion of the Gallbladder Suspected with SPECT-CT: Review and Recommendations. 61
31970008 2020
41
The role of sonography for depiction of a whirlpool sign unrelated to midgut malrotation in neonates. 61
31506737 2020
42
Low ivermectin use among 5- to 6-year-old children: observations from door-to-door surveys in onchocerciasis-endemic regions in Africa. 61
31251354 2020
43
Ischemic bowel secondary to ventriculoperitoneal shunt knotting: a surprisingly rare complication of ventriculoperitoneal shunting. Case report. 61
32005019 2020
44
Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs. 61
31876143 2020
45
Biting Rates and Onchocerca Infectivity Status of Black Flies from the Simulium damnosum Complex (Diptera: Simuliidae) in Osun State, Nigeria. 61
31901168 2020
46
Epidemiology of Large Bowel Carcinoid Tumors in the USA: A Population-Based National Study. 61
31300994 2020
47
Cecal Volvulus in a child with congenital dilated cardiomyopathy: A case report. 61
31790948 2020
48
Early surgical complications after congenital diaphragmatic hernia repair by thoracotomy vs. laparotomy: A bicentric comparison. 61
32005504 2020
49
Symptomatic congenital Morgagni hernia presenting as a chest pain: a case report. 61
31952551 2020
50
Pediatric Cullen gangrene: Case report of postoperative pyoderma gangrenosum in a preterm infant with a complex gastrointestinal malformation. 61
31954341 2020

Variations for Volvulus of Midgut

Expression for Volvulus of Midgut

Search GEO for disease gene expression data for Volvulus of Midgut.

Pathways for Volvulus of Midgut

Pathways related to Volvulus of Midgut according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.44 FOXF1 F2 ALB

GO Terms for Volvulus of Midgut

Biological processes related to Volvulus of Midgut according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 establishment or maintenance of transmembrane electrochemical gradient GO:0010248 9.16 ATP12A ATP4A
2 cellular potassium ion homeostasis GO:0030007 8.96 ATP12A ATP4A
3 sodium ion export across plasma membrane GO:0036376 8.62 ATP12A ATP4A

Molecular functions related to Volvulus of Midgut according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 toxic substance binding GO:0015643 9.26 GUCY2C ALB
2 sodium:potassium-exchanging ATPase activity GO:0005391 9.16 ATP4A ATP12A
3 potassium-transporting ATPase activity GO:0008556 8.96 ATP4A ATP12A
4 potassium:proton exchanging ATPase activity GO:0008900 8.62 ATP4A ATP12A

Sources for Volvulus of Midgut

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....